Today: 29 June 2026
UiPath stock slips after CEO share-sale filing; S&P MidCap 400 flows in focus
4 January 2026
2 mins read

UiPath stock slips after CEO share-sale filing; S&P MidCap 400 flows in focus

NEW YORK, January 4, 2026, 05:53 ET — Market closed.

UiPath Inc shares fell about 3% in the last U.S. session after a Form 4 filing, which discloses insider trades, showed CEO and Chairman Daniel Dines sold stock under a prearranged plan. The automation-software firm’s shares last traded at $15.88 on Friday, down 49 cents from the prior close, after swinging between $15.50 and $16.85 on volume of about 44 million shares. Dines sold 45,000 Class A shares at an average $16.3846 apiece and reported holding 28.4 million shares directly after the sale, plus 9++.6 million shares indirectly, the filing showed.

The disclosure arrives as UiPath entered the S&P MidCap 400 on Friday, a benchmark of mid-sized U.S. companies that many index funds track. S&P Dow Jones Indices said UiPath replaced Synovus Financial in a change effective before the opening bell.

UiPath’s move came on a choppy day for U.S. equities, with the Dow and S&P 500 finishing higher while mega-cap technology names capped gains in the Nasdaq. “The market is seeing a ‘buy the dip, sell the rip’ mentality,” said Joe Mazzola, head of trading and derivatives strategy at Charles Schwab. Reuters

UiPath makes software that automates repetitive work such as moving data between applications, reading emails and updating databases. The approach is often called robotic process automation, or RPA, because the software runs tasks that employees would otherwise do by hand.

Rule 10b5-1 plans are set up in advance and are designed to let executives trade on a schedule, reducing concerns that they used inside information. They do not prevent short-term volatility when investors focus on insider selling patterns.

The company last reported results on Dec. 3, saying revenue rose 16% year-on-year to $411 million and annual recurring revenue, or ARR, reached $1.782 billion as of Oct. 31. ARR is a subscription yardstick that tracks the run-rate value of recurring contracts, and UiPath forecast fiscal fourth-quarter revenue of $462 million to $467 million, with ARR of $1.844 billion to $1.849 billion as of Jan. 31.

Friday’s trade left UiPath below the average price of Dines’ latest sale, even after an early pop. The reversal highlighted how index-related flows and profit-taking can collide around benchmark changes.

With the stock now in the MidCap 400, investors will watch whether trading volume normalizes and whether passive funds keep accumulating shares beyond the initial rebalance. Any additional insider filings and fresh commentary on customer spending in 2026 could also move the stock.

Before the next session, attention turns to U.S. labor-market data due Jan. 9, which investors see as a key input for interest-rate expectations. The Federal Reserve cut rates at each of its last three meetings of 2025, and jobs data could influence how quickly policymakers move again, Reuters reported.

Lower rates tend to support higher-growth software stocks because they make future earnings more valuable in today’s dollars. A strong jobs print, by contrast, can push yields up and weigh on the sector.

UiPath has no upcoming events listed on its investor relations calendar, leaving its next earnings date unconfirmed. Earnings calendars such as Zacks have penciled in March 11 as the expected report date.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Fluor's Russell Index Additions and Pharma Feasibility Studies Could Shift Investment Outlook
    June 29, 2026, 12:41 AM EDT. Fluor Corporation (NYSE: FLR) was added to multiple Russell growth indexes in June 2026, boosting its visibility in key equity benchmarks. Concurrently, it began feasibility studies for Voyageur Pharmaceuticals on an iodine project linked to Bayer and a new contrast media manufacturing facility in North America. These moves might broaden Fluor's market exposure beyond its traditional engineering and construction segments. While the developments support Fluor's backlog and diversification story, analysts caution the near-term focus remains on managing execution risks and cash flow volatility. Fluor projects $18.3 billion revenue and $443.4 million earnings by 2029, requiring steady growth amid potential cost and labor challenges. Investor opinions vary, with some seeing upside potential beyond current valuations, while others stress caution due to operational risks.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Previous Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap
Next Story

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap

Go toTop